MC
GEHC icon

Moors & Cabot’s GE HealthCare GEHC Stock Holding History

Moors & Cabot’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$626K Sell
9,773
-3,379
-26% -$222K 0.02% 506
2026
Q1 		$936K Sell
13,152
-1,359
-9% -$107K 0.04% 387
2025
Q4 		$1.19M Sell
14,511
-2,562
-15% -$200K 0.05% 314
2025
Q3 		$1.28M Buy
17,073
+7,531
+79% +$562K 0.06% 302
2025
Q2 		$707K Buy
9,542
+374
+4% +$26K 0.03% 419
2025
Q1 		$740K Sell
9,168
-607
-6% -$52.2K 0.04% 385
2024
Q4 		$764K Sell
9,775
-125
-1% -$10.6K 0.04% 391
2024
Q3 		$929K Sell
9,900
-64
-0.6% -$5.37K 0.05% 350
2024
Q2 		$776K Sell
9,964
-4,434
-31% -$362K 0.04% 363
2024
Q1 		$1.31M Sell
14,398
-6,115
-30% -$509K 0.07% 249
2023
Q4 		$1.59M Buy
20,513
+133
+0.7% +$9.31K 0.1% 195
2023
Q3 		$1.39M Buy
20,380
+2,713
+15% +$197K 0.09% 207
2023
Q2 		$1.44M Buy
17,667
+2,282
+15% +$182K 0.1% 206
2023
Q1 		$1.26M Buy
+15,385
New +$1.1M 0.09% 231

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Moors & Cabot's GEHC Position: Q2 2026 in Review

Moors & Cabot reduced its GE HealthCare (GEHC) stake by 26% in Q2 2026, selling an estimated $222K and leaving 9,773 shares worth $626K. The position accounts for 0.02% of the portfolio, ranked #506.

Moors & Cabot first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.59M in Q4 2023. 1,232 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Moors & Cabot held 9,773 shares of GE HealthCare worth $626K as of Q2 2026.
  • Moors & Cabot sold 3,379 GE HealthCare shares in Q2 2026, an estimated $222K.
  • GE HealthCare made up 0.02% of Moors & Cabot's portfolio in Q2 2026, its #506 holding.
  • Moors & Cabot first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Moors & Cabot's GE HealthCare position peaked at $1.59M in Q4 2023.
  • 1,232 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.